Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitrile. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel acid-catalyzed acylcyanation of electron-rich alkynes. High selectivity, mild conditions. Cost-effective manufacturing for pharmaceutical intermediates.
Patent CN104003828B details a copper complex catalyzed coupling reaction under visible light, offering cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN112028806B reveals a novel synthetic method for Vildagliptin intermediates, achieving 99.7% purity and 80.6% yield through stabilized cyanuric chloride dehydration.
Advanced synthesis of benzamide intermediates via CN104884427B. Offers superior purity and scalable routes for cardiovascular drug manufacturing.
Patent CN107641622B reveals efficient enzymatic hydrolysis of terephthalonitrile, offering cost reduction in pharmaceutical intermediate manufacturing with high substrate tolerance.
Patent CN110483440A reveals a mild three-step route for high-purity thiazole intermediates. This process offers significant supply chain stability and cost optimization for pharmaceutical manufacturing.
Novel Heck reaction route for HIV drug intermediate IDX-899. High selectivity, mild conditions, scalable manufacturing solution for pharmaceutical intermediates.
Novel melt crystallization patent CN119977839A enables high-purity 2,4-DCBN production with significant cost reduction and supply chain reliability for global buyers.
Patent CN114105877A details a green synthesis of Fipronil intermediates using phase transfer catalysis, offering high purity and reduced environmental impact for agrochemical manufacturing.
Patent CN107759623A reveals high-yield Ruxolitinib intermediate route. Eliminates column chromatography for cost reduction and supply chain reliability in API manufacturing.
Patent CN103319368A reveals a phosphine-catalyzed route offering high yield and mild conditions. This breakthrough ensures cost reduction and supply chain stability for agrochemical manufacturing.
Novel maleate salt formation method for silodosin intermediate ensures high purity and yield, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Novel low-waste synthesis of TosMIC via triphosgene dehydration. Reduces phosphorus waste and improves yield for pharmaceutical intermediate manufacturing.
Patent CN1172804A details a mild hydroxide-mediated cyclization for high-purity 1-substituted-hydantoins. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN105985263B details copper-catalyzed route reducing toxicity. Enhances supply chain reliability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Novel Pd-catalyzed method for unsaturated nitriles using boronic acids. High yield, scalable process for pharma intermediates. Cost-effective supply chain solution.
Novel nickel bromide catalyzed cyanation method offers superior yield and purity for key herbicide intermediates, ensuring reliable supply chain performance.
Patent CN115433103B reveals ionic liquid catalyst method. Eliminates acid neutralization, reduces waste, ensures supply continuity for global buyers.
Patent CN104387291A offers safer scalable synthesis for high purity intermediates reducing supply chain risks and manufacturing costs significantly.
Patent CN105130949A details a safer synthesis route for difluoro cyclopropyl nitrile. This method ensures high purity and supply chain stability for global pharmaceutical manufacturing partners.